Interestingly, we also confirmed the synergic effect of the combination of tamoxifen and metformin in significantly reducing the tumor cell growth of hormone-receptor-positive breast cancer (HR+ BC) cell lines. The gene discussed is NR4A1; the disease is neoplasm.